Skip to main content

Clodronate Therapy of Metastatic Bone Disease in Patients with Prostatic Carcinoma

  • Conference paper
Bisphosphonates and Tumor Osteolysis

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 116))

Abstract

More than 80% of patients with prostatic cancer have skeletal metastasis (Galasko 1981; Abrams et al. 1980). Although hormonal treatment can induce remission of some length, the final outcome is frequently progressive skeletal disease, despite orchiectomy and/or continuous hormone therapy. At this stage, the efficacy of cytotoxic drugs is limited (Posner et al. 1977) and radiation therapy is used only in persons with epidural spinal cord compression. High-dose corticosteroids can produce a short-lasting reduction in symptoms (Yagoda 1983), which should be ascribed to a diminution of the inflammatory reaction around the metastatic lesion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abrams HL, Spiro R, Goldstein N (1980) Metastasis in carcinoma: analysis of 1000 autopsied cases. Cancer 3: 74–85.

    Article  Google Scholar 

  • Adami S, Salvagno G, Guarrera G, Bianchi G, Dorizzi R, Rosini S, Mobilio G, LoCascio V (1985) Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton. J Urol 134: 1152–1154.

    PubMed  CAS  Google Scholar 

  • Galasko C (1981) The anatomy and pathways of skeletal metastasis. In: Weiss L, Gilbert H (eds) Bone metastasis. G. K. Hall, Boston, pp 49–63.

    Google Scholar 

  • Percival RC, Watson ME, Williams JL, Kanis JA (1985) Carcinoma of the prostate: remission of paraparesis with inhibitor of bone resorption. Postgrad Med J 61: 551–553.

    Article  PubMed  CAS  Google Scholar 

  • Posner JB, Howieson J, Cvitkovic E (1977) “Disappearing” spinal cord compression: oncolytic effect of glucocorticoids (and other chemotherapeutic agents) on epidural metastasis. Ann Neurol 2: 409–413.

    Article  PubMed  CAS  Google Scholar 

  • Schnur W (1984) Etidronate for the relief of metastatic bone pain. J Urol 131: 404–407.

    Google Scholar 

  • Urwin GH, Percival RC, Harris S, Beneton MNC, William JL, Kanis JA (1985) Generalised increase in bone resorption in carcinoma of the prostate. Br J Urol 57: 721–723.

    Article  PubMed  CAS  Google Scholar 

  • Yagoda A (1983) Response in prostatic cancer: an enigma. Semin Urol 1: 311–323.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Adami, S., Mian, M. (1989). Clodronate Therapy of Metastatic Bone Disease in Patients with Prostatic Carcinoma. In: Brunner, K.W., Fleisch, H., Senn, HJ. (eds) Bisphosphonates and Tumor Osteolysis. Recent Results in Cancer Research, vol 116. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83668-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83668-8_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-83670-1

  • Online ISBN: 978-3-642-83668-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics